Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Archean Chemical Industries IPO is 52. Their analysis recommends Must Subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 52 | Must Subscribe |
[Dilip Davda] ACIL has created a niche place as a specialty chemical manufacturer and exporter. It has started bearing fruits for its undergoing downstream expansions that have helped in improving margins. Based on its FY23 earnings, the issue appears reasonably priced. Considering ongoing fancy for specialty chemical shares, investors may consider investing in this blue chip in the offing for medium to long-term rewards. Read detail review...
Archean Chemical Industries IPO Reviews, analysis and views by popular members. Read Archean Chemical Industries Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note:
Useful Articles